Literature DB >> 2170359

Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation.

R Lammers1, E Van Obberghen, R Ballotti, J Schlessinger, A Ullrich.   

Abstract

Fully functional chimeric receptors, consisting of major epidermal growth factor and insulin receptor domains, were co-expressed with kinase-negative epidermal growth factor and insulin receptor mutants in human kidney fibroblasts. Under these conditions, homologous extracellular and cytoplasmic domains mediated association of receptors and their precursors. The significance of receptor-receptor interaction was confirmed by transphosphorylation of kinase-negative receptors by ligand-activated chimeric receptors, which was observed between receptors sharing the same cytoplasmic domain as well as between receptors bearing only the same extracellular domain and containing heterologous kinases. Furthermore, the impaired ligand internalization capacity of a kinase-deficient insulin receptor was partially restored by transphosphorylation. Our experiments suggest interreceptor transphosphorylation and transactivation as a possible mechanism for signal amplification.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170359

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Association and phosphorylation-dependent dissociation of proteins in the insulin receptor complex.

Authors:  W Zhang; J D Johnson; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

2.  The interaction between the Drosophila secreted protein argos and the epidermal growth factor receptor inhibits dimerization of the receptor and binding of secreted spitz to the receptor.

Authors:  M H Jin; K Sawamoto; M Ito; H Okano
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

Authors:  Michael D Paul; Kalina Hristova
Journal:  Chem Rev       Date:  2018-12-27       Impact factor: 60.622

4.  Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation.

Authors:  C Liebow; M T Lee; A R Kamer; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16.

Authors:  C K Jiang; T Magnaldo; M Ohtsuki; I M Freedberg; F Bernerd; M Blumenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

6.  Erythropoietin receptors induced by dimethyl sulfoxide exhibit positive cooperativity associated with an amplified biologic response.

Authors:  S Yonekura; Y Chern; K A Donahue; L Feldman; G J Vanasse; A J Sytkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

Authors:  C Sell; G Dumenil; C Deveaud; M Miura; D Coppola; T DeAngelis; R Rubin; A Efstratiadis; R Baserga
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

8.  Symmetric signaling by an asymmetric 1 erythropoietin: 2 erythropoietin receptor complex.

Authors:  Yingxin L Zhang; Mala L Radhakrishnan; Xiaohui Lu; Alec W Gross; Bruce Tidor; Harvey F Lodish
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

9.  Synergistic effects of bombesin and epidermal growth factor on cancers.

Authors:  C Liebow; D H Crean; M T Lee; A R Kamer; T S Mang; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Cyclic AMP impairs the rapid effect of insulin to enhance cell-surface insulin-binding capacity in rat adipocytes.

Authors:  J W Eriksson; P Lönnroth; U Smith
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.